|
|
|
|
|
|
|
|
|
|
|
03.08.26 - 22:09
|
Medifast Announces Second Quarter 2026 Financial Results (Business Wire)
|
|
|
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, today reported results for the second quarter ended June 30, 2026.
Second Quarter 2026
Revenue: $76.4 million, with revenue per active earning coach of $6,529
Independent active earning coaches of 11,700
Net loss of $3.1 million or $0.28 loss per diluted share ("EPS")
Cash, Cash Equivalents, and Investment Securities of $169.8 million with no debt
Nick Johnson, Chief Executive Officer, commented, “In the second quarter, we continued to see signs of a turnaround in our business. Revenue remained sequentially stable, supported by steady growth in coach productivity and positive coach leadership trends. Combined with the energy and engagement demonstrated at our recent National Coach Convention, these leading indicators have historically been precursors of future growth.
“We're building on that progress by putting new tools in our coache...
|
|
|
|
|
|
|
|
|
20.07.26 - 22:06
|
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026 (Business Wire)
|
|
|
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, will announce financial results for the quarter ended June 30, 2026 on Monday, August 3, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Nick Johnson, Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
The conference call is scheduled to begin at 4:30 p.m. ET on August 3, 2026. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1768081&tp_key=644d7ae69f and will be archived online and available through November 3, 2026. To join via telephone, listeners may dial (201) 389-0879.
A telephonic playback will be available from 8:30 p.m. ET, August 3, 2026, through August 10, 2026...
|
|
|
|
|
|
|
|
|
26.05.26 - 22:06
|
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer (Business Wire)
|
|
|
Johnson will succeed Dan Chard as CEO; Chard to remain Chairman of the BoardBALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced that its Board of Directors has formally appointed Nicholas Johnson as Chief Executive Officer, effective June 1, 2026. Johnson will succeed Dan Chard as CEO, who will continue to serve as Chairman of the Board.
The appointment follows the leadership transition plan that the company disclosed in January and reflects the Board's confidence in Johnson's leadership and the company's strategic direction. Chard will remain actively engaged as Chairman of the Board, supporting Johnson and the leadership team while continuing to provide strategic oversight.
“Nick has been a driving force behind our transformation into a comprehensive metabolic health company, and the Board is confident that he is the right leader to guide Medifast into its next chapter,” said Dan Chard, Chairman and outgoing Chief Executive Officer of Medifast. “Over the past several years, w...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
